Good news! However, tainted by the ideology of racism!
According to Johns Hopkins University, CNN, and New York Times this had to be turned into an ideology of racism event: "A US woman of mixed race has gone into HIV remission after a stem cell transplant from umbilical cord blood—marking the third-ever time someone appears to have been cured of HIV, and the first using this approach ... Researchers said the method’s success has especially encouraging implications for people of more racially diverse backgrounds ..."
Very annoying!!! What the heck does this have to do with race!!!
"UCLA researchers presented today the first case of a U.S. woman living with HIV-1 that is in remission after she received a new combination of specialized stem cell transplants for treatment of acute myeloid leukemia (AML). ...
This woman has been in remission of AML for 4½ years and has had no HIV rebound in the 14 months since antiretroviral therapy was stopped ...
If HIV remission continues and she is determined to be cured, she would be only the third person to achieve cure and the first HIV remission to have been successfully engrafted with umbilical cord blood cells with a mutation that is protective against HIV-1 (CCR5-delta32/32 homozygous) combined with stem cells from an adult, haploidentical (“half-matched”) related donor. ...
The CCR5-delta32 mutation is rare, but cord blood banks may provide a previously untapped resource, according to the researchers, and the combination therapy would enable clinicians to take advantage of the unique benefits offered by each type of graft for more diverse populations. ..."
This woman has been in remission of AML for 4½ years and has had no HIV rebound in the 14 months since antiretroviral therapy was stopped ...
If HIV remission continues and she is determined to be cured, she would be only the third person to achieve cure and the first HIV remission to have been successfully engrafted with umbilical cord blood cells with a mutation that is protective against HIV-1 (CCR5-delta32/32 homozygous) combined with stem cells from an adult, haploidentical (“half-matched”) related donor. ...
The CCR5-delta32 mutation is rare, but cord blood banks may provide a previously untapped resource, according to the researchers, and the combination therapy would enable clinicians to take advantage of the unique benefits offered by each type of graft for more diverse populations. ..."
No comments:
Post a Comment